TechInvention partners with Ethiopia's Ministry of Health to advance vaccine manufacturing in Africa

In a significant step toward enhancing vaccine self-sufficiency and pandemic preparedness in Africa, TechInvention, an Indian biotech company, has entered into an agreement with Ethiopia's Ministry of Health.

This initiative supports Ethiopia's goals under the African Union’s Agenda 2063 and the Partnership for African Vaccine Manufacturing (PAVM), both of which aim to strengthen healthcare systems and build resilience across the continent.

TechInvention will play a crucial role in this groundbreaking initiative by providing comprehensive technical and strategic support throughout the vaccine manufacturing project. This includes updating the feasibility study, developing the design of the manufacturing facility, conducting geotechnical investigations, and assessing environmental and social impacts.

The company will also oversee the creation of technical specifications, prepare tender documents for contractor selection, develop bill of quantities, and offer support in product and process technology selection, acquisition, and transfer.

As part of its advisory role, TechInvention will guide the Ethiopian Ministry of Health and other stakeholders on project implementation, ensuring the development of a state-of-the-art vaccine manufacturing facility that adheres to international quality standards.

The official signing ceremony took place recently in Addis Ababa, with Dr Mekdes Daba, Minister of Health, Ethiopia, and Syed Ahmed, Director and CEO of TechInvention, formalising the agreement.